Found: 96
Select item for more details and to access through your institution.
Early Metabolic Endpoints Identify Persistent Treatment Efficacy in Recent-Onset Type 1 Diabetes Immunotherapy Trials.
- Published in:
- Diabetes Care, 2024, v. 47, n. 6, p. 1048, doi. 10.2337/dc24-0171
- By:
- Publication type:
- Article
HOMA-IR and the Matsuda Index as predictors of progression to type 1 diabetes in autoantibody-positive relatives.
- Published in:
- Diabetologia, 2024, v. 67, n. 2, p. 290, doi. 10.1007/s00125-023-06034-y
- By:
- Publication type:
- Article
Phenotypes Associated With Zones Defined by Area Under the Curve Glucose and C-peptide in a Population With Islet Autoantibodies.
- Published in:
- Diabetes Care, 2023, v. 46, n. 5, p. 1098, doi. 10.2337/dc22-2236
- By:
- Publication type:
- Article
Persistence of β-Cell Responsiveness for Over Two Years in Autoantibody-Positive Children With Marked Metabolic Impairment at Screening.
- Published in:
- Diabetes Care, 2022, v. 45, n. 12, p. 2982, doi. 10.2337/dc22-1362
- By:
- Publication type:
- Article
Index60 Is Superior to HbA1c for Identifying Individuals at High Risk for Type 1 Diabetes.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2022, v. 107, n. 10, p. 2784, doi. 10.1210/clinem/dgac440
- By:
- Publication type:
- Article
Index60 Identifies Individuals at Appreciable Risk for Stage 3 Among an Autoantibody-Positive Population With Normal 2-Hour Glucose Levels: Implications for Current Staging Criteria of Type 1 Diabetes.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Do-It-Yourself Diabetes Management: Perspectives of a Patient, a Physician, and an Ethicist.
- Published in:
- Clinical Diabetes, 2022, v. 40, n. 1, p. 70, doi. 10.2337/cd20-0058
- By:
- Publication type:
- Article
The Deterrence of Rapid Metabolic Decline Within 3 Months After Teplizumab Treatment in Individuals at High Risk for Type 1 Diabetes.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Time to Peak Glucose and Peak C-Peptide During the Progression to Type 1 Diabetes in the Diabetes Prevention Trial and TrialNet Cohorts.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Genetic Variants Do Not Influence Insulin Sensitivity or Secretion Indices in Autoantibody-Positive Individuals at Risk for Type 1 Diabetes.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Index60 as an additional diagnostic criterion for type 1 diabetes.
- Published in:
- Diabetologia, 2021, v. 64, n. 4, p. 836, doi. 10.1007/s00125-020-05365-4
- By:
- Publication type:
- Article
The Effect of Ethnicity in the Rate of Beta-Cell Functional Loss in the First 3 Years After Type 1 Diabetes Diagnosis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The Pathological Evolution of Glucose Response Curves During the Progression to Type 1 Diabetes in the TrialNet Pathway to Prevention Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
One-Hour Oral Glucose Tolerance Tests for the Prediction and Diagnostic Surveillance of Type 1 Diabetes.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Slowed Metabolic Decline After 1 Year of Oral Insulin Treatment Among Individuals at High Risk for Type 1 Diabetes in the Diabetes Prevention Trial-Type 1 (DPT-1) and TrialNet Oral Insulin Prevention Trials.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The risk of progression to type 1 diabetes is highly variable in individuals with multiple autoantibodies following screening.
- Published in:
- Diabetologia, 2020, v. 63, n. 3, p. 588, doi. 10.1007/s00125-019-05047-w
- By:
- Publication type:
- Article
The Association Between Heart Rate and Glycemic Status in the National Health and Nutrition Examination Surveys.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Provider-Guided Emergency Support for Persons Living With Type 1 Diabetes During Hurricanes Harvey, Irma, and Maria.
- Published in:
- Disaster Medicine & Public Health Preparedness, 2020, v. 14, n. 1, p. 150, doi. 10.1017/dmp.2020.17
- By:
- Publication type:
- Article
1469-P: Associations between Heart Rate, Glycemia, and A1c Levels.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1469-P
- By:
- Publication type:
- Article
85-OR: Modifiers of C-Peptide Change during the Progression to Type 1 Diabetes (T1D) in the TrialNet Pathway to Prevention Study.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-85-OR
- By:
- Publication type:
- Article
1343-P: A Comparison of C-Peptide and Glucose Responses between Children and Adolescents Who Progress to Type 1 Diabetes (T1D).
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1343-P
- By:
- Publication type:
- Article
1689-P: Assessments of Alternative C-Peptide (C-P) Endpoints for New-Onset Type 1 Diabetes (T1D) Clinical Trials.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1689-P
- By:
- Publication type:
- Article
1678-P: Comparisons of Combined C-Peptide and Glucose Intermediate Endpoints for Identifying Individuals at Very High Risk for Type 1 Diabetes.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1678-P
- By:
- Publication type:
- Article
187-LB: Glucose Response Curve (GRC) Shapes in Mixed Meal Tolerance Tests (MMTTs) and Prediction of Response to Intervention in the TrialNet New-Onset Clinical Trials.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-187-LB
- By:
- Publication type:
- Article
1684-P: Using Index60 to Detect Heterogeneity and Identify Subpopulations with Characteristic Type 1 Diabetes (T1D) Profiles among Individuals with Normal Two-Hour Glucose Levels.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1684-P
- By:
- Publication type:
- Article
1671-P: Comorbid Autoimmune Disease in Participants at Risk for Type 1 Diabetes.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1671-P
- By:
- Publication type:
- Article
1344-P: Persistent ß-Cell Responsiveness in Children at High Risk for Type 1 Diabetes (T1D) Is Associated with Decreased Progression to T1D in the Diabetes Prevention Trial-Type 1 (DPT-1).
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1344-P
- By:
- Publication type:
- Article
Associations of HbA1c with the timing of C‐peptide responses during the oral glucose tolerance test at the diagnosis of type 1 diabetes.
- Published in:
- Pediatric Diabetes, 2019, v. 20, n. 4, p. 408, doi. 10.1111/pedi.12845
- By:
- Publication type:
- Article
The Effect of Age on the Progression and Severity of Type 1 Diabetes: Potential Effects on Disease Mechanisms.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The influence of body mass index and age on C‐peptide at the diagnosis of type 1 diabetes in children who participated in the diabetes prevention trial‐type 1.
- Published in:
- Pediatric Diabetes, 2018, v. 19, n. 3, p. 403, doi. 10.1111/pedi.12609
- By:
- Publication type:
- Article
Erratum. Validation of the Diabetes Prevention Trial-Type 1 Risk Score in the TrialNet Natural History Study. Diabetes Care 2011;34:1785-1787.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
The shape of the glucose concentration curve during an oral glucose tolerance test predicts risk for type 1 diabetes.
- Published in:
- Diabetologia, 2018, v. 61, n. 1, p. 84, doi. 10.1007/s00125-017-4453-6
- By:
- Publication type:
- Article
Dysglycemia and Index60 as Prediagnostic End Points for Type 1 Diabetes Prevention Trials.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Impact of Age and Antibody Type on Progression From Single to Multiple Autoantibodies in Type 1 Diabetes Relatives.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Diabetic Neuropathy: A Position Statement by the American Diabetes Association.
- Published in:
- 2017
- By:
- Publication type:
- journal article
HLA-DRB1*15:01-DQA1*01:02-DQB1*06:02 Haplotype Protects Autoantibody-Positive Relatives From Type 1 Diabetes Throughout the Stages of Disease Progression.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association.
- Published in:
- 2015
- By:
- Publication type:
- journal article
The development and utility of a novel scale that quantifies the glycemic progression toward type 1 diabetes over 6 months.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
βCell death and dysfunction during type 1 diabetes development in at-risk individuals.
- Published in:
- Journal of Clinical Investigation, 2015, v. 125, n. 3, p. 1163, doi. 10.1172/JCI78142
- By:
- Publication type:
- Article
A new approach for diagnosing type 1 diabetes in autoantibody-positive individuals based on prediction and natural history.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Use of the Diabetes Prevention Trial-Type 1 Risk Score (DPTRS) for Improving the Accuracy of the Risk Classification of Type 1 Diabetes.
- Published in:
- Diabetes Care, 2014, v. 37, n. 4, p. 979, doi. 10.2337/dc13-2359
- By:
- Publication type:
- Article
Acceleration of the Loss of the First-Phase Insulin Response During the Progression to Type 1 Diabetes in Diabetes Prevention Trial-Type 1 Participants.
- Published in:
- Diabetes, 2013, v. 62, n. 12, p. 4179, doi. 10.2337/db13-0656
- By:
- Publication type:
- Article
The Prediction of Type 1 Diabetes by Multiple Autoantibody Levels and Their Incorporation Into an Autoantibody Risk Score in Relatives of Type 1 Diabetic Patients.
- Published in:
- Diabetes Care, 2013, v. 36, n. 9, p. 2615, doi. 10.2337/dc13-0425
- By:
- Publication type:
- Article
The Evolution of Type 1 Diabetes.
- Published in:
- 2013
- By:
- Publication type:
- Editorial
Prognostic Accuracy of Immunologic and MetabolicMarkers for Type 1 Diabetes in a High-Risk Population.
- Published in:
- Diabetes Care, 2012, v. 35, n. 10, p. 1975, doi. 10.2337/dc12-0183
- By:
- Publication type:
- Article
Prognostic accuracy of immunologic and metabolic markers for type 1 diabetes in a high-risk population: receiver operating characteristic analysis.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Fall in C-Peptide During First 2 Years From Diagnosis.
- Published in:
- Diabetes, 2012, v. 61, n. 8, p. 2066, doi. 10.2337/db11-1538
- By:
- Publication type:
- Article
The application of the diabetes prevention trial-type 1 risk score for identifying a preclinical state of type 1 diabetes.
- Published in:
- 2012
- By:
- Publication type:
- journal article
The Application of the Diabetes Prevention Trial--Type 1 Risk Score for Identifying a Preclinical State of Type 1 Diabetes.
- Published in:
- Diabetes Care, 2012, v. 35, n. 7, p. 1552, doi. 10.2337/dc12-0011
- By:
- Publication type:
- Article